Glutathione synthetase (GSS) is involved in the final step of glutathione production, while glutathione peroxidases (GPXs) help use it to neutralize harmful reactive oxygen species
Systemic versus topical approach Unlike KPV and GHK-Cu, which are primarily studied as topical applications for skin conditions, TB-500 works systemically
10.1016/j.pediatrneurol.2005.03.014 11
In general, when MB is used chronically or for off-label indications (such as cognitive support or chronic illness), clinicians employ a start low and go slow approach, beginning with small doses and adjusting as needed
Typical Duration of Therapy The duration of BPC-157 therapy varies based on the conditions severity: Acute injuries or mild inflammation: 24 weeks Moderate injuries or post-surgical recovery: 48 weeks Chronic or systemic conditions: 812 weeks or longer For best outcomes, BPC-157 may be combined with TB-500, Thymosin Beta-4, or KPV peptides, along with targeted nutrition and physiologic optimization